P

PTC Therapeutics
D

PTCT

40.370
USD
-9.53
(-19.10%)
مفتوح الان
حجم التداول
102,550
الربح لكل سهم
3
العائد الربحي
-
P/E
-9
حجم السوق
3,198,822,800
أصول ذات صلة
BMRN
BMRN
0.150
(0.24%)
62.130 USD
E
ESPR
-0.00500
(-0.46%)
1.07500 USD
INCY
INCY
-0.010
(-0.02%)
62.490 USD
NBIX
NBIX
0.600
(0.55%)
110.350 USD
Q
QURE
0.950
(6.43%)
15.720 USD
R
RARE
-0.191
(-0.49%)
39.140 USD
REGN
REGN
0.77
(0.13%)
606.89 USD
S
SRPT
0.080
(0.13%)
63.630 USD
VRTX
VRTX
2.85
(0.57%)
503.37 USD
المزيد
الأخبار المقالات

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.